| 摘要 |
<p>The invention concerns the use of at least an antidiabetic selected among compounds stimulation insulin secretion, glucosidase inhibitors, thiazolidine-diones, insulin, agents enhancing insulin sensitivity, the glucagon-like peptide-1 (GLP-1), PPARα/η agonists, meglitinide and aP2 inhibitors for making a medicine with cicatrizing effect.</p> |
